Syngen Biotech Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2018
November 07, 2018 at 02:14 pm EST
Share
Syngen Biotech Co., Ltd. announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced sales was TWD 309.564 million compared to TWD 271.851 million a year ago. Operating income was TWD 57.420 million compared to TWD 61.777 million a year ago. Net income was TWD 47.950 million compared to TWD 57.935 million a year ago. Basic earnings per share was TWD 2.08 compared to TWD 2.51 a year ago. Diluted earnings per share was TWD 2.07 compared to TWD 2.51 a year ago.
For the nine months, sales was TWD 766.132 million compared to TWD 724.968 million a year ago. Operating income was TWD 115.149 million compared to TWD 142.782 million a year ago. Net income was TWD 90.623 million compared to TWD 122.789 million a year ago. Basic earnings per share was TWD 3.92 compared to TWD 5.32 a year ago. Diluted earnings per share was TWD 3.92 compared to TWD 5.31 a year ago.
Syngen Biotech Co Ltd is a Taiwan-based company mainly engaged in the manufacture and distribution of active pharmaceutical ingredients and health food products. The Companyâs products mainly consist of active pharmaceutical ingredients, health food raw materials, medical equipment, such as bone density analyzers, blood glucose analyzers and biochemical analyzers, as well as animal health products and others. The Company distributes its products mainly in Taiwan, Iran, South Korea and Egypt.
SYNGEN BIOTECH CO.,LTD. 
